Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | +1.87% |
|
+0.62% | +7.74% |
Financials (USD)
Sales 2024 * | 2.67B | Sales 2025 * | 2.79B | Capitalization | 1.98B |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | 23M | EV / Sales 2024 * | 1.62 x |
Net Debt 2024 * | 2.35B | Net Debt 2025 * | 2.12B | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-24.2
x | P/E ratio 2025 * |
93.4
x | Employees | 7,850 |
Yield 2024 * |
0.46% | Yield 2025 * |
-
| Free-Float | 26.13% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | +1.87% | ||
1 week | -0.15% | ||
Current month | +2.99% | ||
1 month | -2.10% | ||
3 months | +8.10% | ||
6 months | +7.74% | ||
Current year | +7.74% |
![Extreme 6.29](/images/extremecours_fleche.png)
![Extreme 6.29](/images/extremecours_fleche.png)
![Extreme 5.01](/images/extremecours_fleche.png)
![Extreme 2.29](/images/extremecours_fleche.png)
![Extreme 1.24](/images/extremecours_fleche.png)
![Extreme 1.24](/images/extremecours_fleche.png)
![Extreme 1.24](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 6.54 | +1.87% | 974,297 |
24-07-01 | 6.42 | +1.10% | 911,778 |
24-06-28 | 6.35 | -1.09% | 9,101,889 |
24-06-27 | 6.42 | -0.77% | 962,859 |
24-06-26 | 6.47 | -0.46% | 1,438,932 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.74% | 1.98B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- AMRX Stock